Adjuvant Chemotherapy [topp]    
Resectable Cholangiocarcinoma [neop]    
Patients [podg]    
Patients [podg]    
Usually [qlco]    
Poor outcome [fndg]    
treatment [ftcn]    
Mortality rate [qnco]    
Adjuvant Chemotherapy [topp]    
controversy [socb]    
Study [mnob]    
Evaluate [hlca]    
Benefits [qnco]    
Adjuvant Chemotherapy [topp]    
Resectable Cholangiocarcinoma [neop]    
Patients [podg]    
Retrospective Study [resa]    
included [ftcn]    
Patients [podg]    
Curative [cnce]    
resection [topp]    
Patients [podg]    
Pathology Report [inpr]    
Clear Margin [fndg]    
Microscopic [qlco]    
Margin [spco]    
R1 [gngm]    
free [ftcn]    
TISSUE [tisu]    
Patients [podg]    
RECEIVED [qlco]    
Adjuvant Chemotherapy [topp]    
Group [idcn]    
LOWER [spco]    
Patients [podg]    
Receive [qlco]    
Adjuvant Chemotherapy [topp]    
Group [idcn]    
YEARS [tmco]    
Serum Albumin [aapp]    
Adjuvant Chemotherapy [topp]    
Group [idcn]    
Receive [qlco]    
Adjuvant Chemotherapy [topp]    
Patients [podg]    
RECEIVED [qlco]    
Adjuvant Chemotherapy [topp]    
Long [qlco]    
Median Survival Time [tmco]    
Patients [podg]    
Combination [qlco]    
Regimen [topp]    
Longest [qlco]    
Survival time [clna]    
Median Survival Time [tmco]    
Alone [qnco]    
Alone [qnco]    
Alone [qnco]    
Benefits [qnco]    
Adjuvant Chemotherapy [topp]    
Likely [qlco]    
Patients [podg]    
risk Feature [qnco]    
Advanced Stage [qlco]    
T4 Stage [fndg]    
Lymph Node Involvement [fndg]    
R1 [gngm]    
Margin [spco]    
Survival time [clna]    
Resectable Cholangiocarcinoma [neop]    
Patients [podg]    
high-risk group [popg]    
